1. Home
  2. PRME vs MGIC Comparison

PRME vs MGIC Comparison

Compare PRME & MGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • MGIC
  • Stock Information
  • Founded
  • PRME 2019
  • MGIC 1983
  • Country
  • PRME United States
  • MGIC Israel
  • Employees
  • PRME N/A
  • MGIC N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • MGIC Computer Software: Prepackaged Software
  • Sector
  • PRME Health Care
  • MGIC Technology
  • Exchange
  • PRME Nasdaq
  • MGIC Nasdaq
  • Market Cap
  • PRME 588.2M
  • MGIC 530.3M
  • IPO Year
  • PRME 2022
  • MGIC 1991
  • Fundamental
  • Price
  • PRME $4.05
  • MGIC $11.34
  • Analyst Decision
  • PRME Strong Buy
  • MGIC Buy
  • Analyst Count
  • PRME 9
  • MGIC 1
  • Target Price
  • PRME $14.75
  • MGIC $14.00
  • AVG Volume (30 Days)
  • PRME 502.4K
  • MGIC 59.5K
  • Earning Date
  • PRME 11-01-2024
  • MGIC 08-14-2024
  • Dividend Yield
  • PRME N/A
  • MGIC 1.92%
  • EPS Growth
  • PRME N/A
  • MGIC N/A
  • EPS
  • PRME N/A
  • MGIC 0.72
  • Revenue
  • PRME $591,000.00
  • MGIC $523,332,000.00
  • Revenue This Year
  • PRME N/A
  • MGIC $3.87
  • Revenue Next Year
  • PRME N/A
  • MGIC $3.39
  • P/E Ratio
  • PRME N/A
  • MGIC $14.89
  • Revenue Growth
  • PRME N/A
  • MGIC N/A
  • 52 Week Low
  • PRME $3.47
  • MGIC $8.15
  • 52 Week High
  • PRME $13.09
  • MGIC $12.99
  • Technical
  • Relative Strength Index (RSI)
  • PRME 44.46
  • MGIC 63.04
  • Support Level
  • PRME $3.47
  • MGIC $10.24
  • Resistance Level
  • PRME $4.40
  • MGIC $10.78
  • Average True Range (ATR)
  • PRME 0.29
  • MGIC 0.26
  • MACD
  • PRME 0.04
  • MGIC 0.04
  • Stochastic Oscillator
  • PRME 48.33
  • MGIC 91.67

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About MGIC Magic Software Enterprises Ltd.

Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. It generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel; Europe; Japan, and Other countries.

Share on Social Networks: